MOLECULAR & CELLULAR PROTEOMICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2024-01-03 TT1245 来自北京

降到了中科院二院，top期刊也没了，真是无语

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2017-11-13 ms7999216884373889

虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！

145 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2015-12-03 ms6502024518793471

审稿速度:1.0
经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2020-12-09 GuijunGuan

审稿速度:3.0 | 投稿命中率:50.0
经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响

151 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2021-12-29 rayms

ORCIDID是什么？怎么注册？

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2020-10-20 12263d8am82暂无昵称

审稿速度:12.0 | 投稿命中率:5.0
经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少

156 0

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2020-10-20 12263d8am82暂无昵称

审稿速度:6.0 | 投稿命中率:5.0
经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高

141 0

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2019-09-17 123e2033m26暂无昵称

格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。

212 0

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2019-03-04 1e1262fam48(暂无匿称)

外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表::
接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表:
2月2号投稿，3月3号被拒，2个reviewers

angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers

205 0

[GetPortalCommentsPageByObjectIdResponse(id=2178968, encodeId=b78521e8968f5, content=降到了中科院二院，top期刊也没了，真是无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93fc2297308, createdName=TT1245, createdTime=Wed Jan 03 10:19:19 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=839278, encodeId=04e18392e805, content=虽然个人对中国的生命科学研究充满信心，但也注意到中国科研界出现的许多问题，尤其是在分子生物学领域。一个韩春雨倒下了，主要是自己玩大了，想想如果韩不是投的ng，而是这5-10分的杂志，或许并不会引起这么大的波澜。本人自己在的实验室一些基本的实验（诸如western blot）都重复不出来，而老板又逼迫的很紧，师兄师姐中自己小小地篡改一下实验结果已结心知肚明，陆陆续续地都发表在了mcp，jp，pp等杂志上。组会上老板经常大放厥词，在他眼里我们只是廉价的劳动力，只需要拿实验结果就行，哎，对老板失望！这个博士也实在读不下去了！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Mon Nov 13 08:45:51 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831327, encodeId=97df83132ed5, content=审稿速度:1.0 经验分享：投了20天，一周前说送给副编辑了，给我发了封邮件，是不是送外审也会给我发邮件？现在状态一直没变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Thu Dec 03 11:23:56 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906467, encodeId=263590646ed0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从投稿到评审返修2个月，回答评审的意见稿就写了4000字左右，二审花了17天，今天接收了。需要上传蛋白组学和质谱的原始数据。编辑和评审都很严谨，提了许多问题，我们都细致地回答说明，以理服人后就被接收了，没有被要求追加实验或其他要求，还给了版面费减免一半的优惠。希望MCP和JBC，Development等一样保持学术严谨特色，不受IF摆布和影响, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ade108928, createdName=GuijunGuan, createdTime=Wed Dec 09 20:47:55 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098708, encodeId=539e1098e08f7, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893388, encodeId=e3698933883d, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：偏分析化学，生物质谱，蛋白质组学，必须要有验证实验，格式要求高，今年文章质量明显提高，灌水文章很少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:37:34 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893386, encodeId=22078933860f, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：期刊文章质量不错，难度挺大，蛋白质组领域顶级期刊，文章格式和数据质量要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Tue Oct 20 20:35:45 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576460, encodeId=dcf45e6460aa, content=格式复杂，偏向质谱技术，5分没到，真是可惜又浪费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd512444948, createdName=123e2033m26暂无昵称, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567577, encodeId=5b0756e5779f, content=外审后被拒稿还可以希望再审稿一次吗angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewersangiexiaojie 2015-03-04 09:08:00 发表: 2月2号投稿，3月3号被拒，2个reviewers, beContent=angiexiaojie 2015-03-04 发表:: 接收率：约25% 审稿时间：约1个月 2月2号投稿，3月3号被拒，2个reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161125/IMG5837E39E531196804.jpg, createdBy=de121956142, createdName=1e1262fam48(暂无匿称), createdTime=Mon Mar 04 00:00:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558673, encodeId=31355586e35a, content=还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, beContent=殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=)]

2018-06-30 sunliang

还敢投啊.一直在降分.这杂志辉煌不再了殴打小朋友5188b890 2018-03-31 18:01:00 发表:
今日投了一篇.祝福自己!

殴打小朋友5188b890 2018-03-31 18:01:00 发表: 今日投了一篇.祝福自己!

369 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务